{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:02:05Z","timestamp":1767916925064,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.pmr.2011.11.001","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T09:19:14Z","timestamp":1323854354000},"page":"59-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hypohomocysteinemia: A Potentially Treatable Cause of Peripheral Neuropathology?"],"prefix":"10.1016","volume":"23","author":[{"given":"Clark E.","family":"Cullen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory T.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Scott","family":"Saperstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pmr.2011.11.001_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000052822","article-title":"Plasma folate, vitamin B-12, and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer\u2019s dementia. A case-control study","volume":"47","author":"Postiglione","year":"2001","journal-title":"Gerontology"},{"issue":"10","key":"10.1016\/j.pmr.2011.11.001_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2036.2011.04864.x","article-title":"Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases","volume":"34","author":"Oussalah","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pmr.2011.11.001_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.nu.12.070192.000423","article-title":"Cobalamin deficiency and the pathogenesis of nervous system disease","volume":"12","author":"Metz","year":"1992","journal-title":"Annu Rev Nutr"},{"issue":"Suppl 10","key":"10.1016\/j.pmr.2011.11.001_bib4","first-page":"28","article-title":"The role of folate in depression and dementia","volume":"68","author":"Mischoulon","year":"2007","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.pmr.2011.11.001_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00001756-200404090-00025","article-title":"Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer\u2019s disease","volume":"15","author":"Anello","year":"2004","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.pmr.2011.11.001_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00003495-199448020-00002","article-title":"The clinical potential of admetionine (S-adenosylmethionine) in neurologic disorders","volume":"48","author":"Bottiglieri","year":"1994","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.pmr.2011.11.001_bib7","doi-asserted-by":"crossref","first-page":"e12244","DOI":"10.1371\/journal.pone.0012244","article-title":"Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial","volume":"5","author":"Smith","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pmr.2011.11.001_bib8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.pnpbp.2005.06.021","article-title":"Homocysteine and folate metabolism in depression","volume":"29","author":"Bottiglieri","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pmr.2011.11.001_bib9","series-title":"Folate in health and disease","first-page":"330","article-title":"Folate and neurologic function: epidemiologic perspective","author":"Morris","year":"2010"},{"issue":"9","key":"10.1016\/j.pmr.2011.11.001_bib10","doi-asserted-by":"crossref","first-page":"e25142","DOI":"10.1371\/journal.pone.0025142","article-title":"Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pmr.2011.11.001_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006612.pub2","article-title":"Homocysteine lowering interventions for preventing cardiovascular events","volume":"4","author":"Mart\u00ed-Carvajal","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.pmr.2011.11.001_bib12","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1517\/14656566.2.9.1449","article-title":"Homocysteine-lowering treatment: an overview","volume":"2","author":"van Guldener","year":"2001","journal-title":"Expert Opin Pharmacother"},{"issue":"17","key":"10.1016\/j.pmr.2011.11.001_bib13","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1016\/j.pmr.2011.11.001_bib14","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1177\/15648265080292S116","article-title":"Public health significance of elevated homocysteine","volume":"29","author":"Selhub","year":"2008","journal-title":"Food Nutr Bull"},{"key":"10.1016\/j.pmr.2011.11.001_bib15","series-title":"Folate in health and disease","first-page":"355","article-title":"Folate and neurologic disease: basic mechanisms","author":"Bottiglieri","year":"2010"},{"issue":"2","key":"10.1016\/j.pmr.2011.11.001_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/wrna.63","article-title":"Recognition of S-adenosylmethionine by riboswitches","volume":"2","author":"Batey","year":"2011","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"5","key":"10.1016\/j.pmr.2011.11.001_bib17","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI40000","article-title":"Folate regulation of axonal regeneration in the rodent central nervous system through DNA methylation","volume":"120","author":"Iskandar","year":"2010","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.pmr.2011.11.001_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10545-010-9127-1","article-title":"Complete deficiency of methylenetetrahydrofolate reductase in mice is associated with impaired retinal function and variable mortality, hematological profiles, and reproductive outcomes","volume":"34","author":"Lawrance","year":"2011","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.pmr.2011.11.001_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1051\/medsci\/2007233297","article-title":"Molecular genetics of MTHFR: polymorphisms are not all benign","volume":"23","author":"Leclerc","year":"2007","journal-title":"Med Sci (Paris)"},{"issue":"3","key":"10.1016\/j.pmr.2011.11.001_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10545-007-0445-x","article-title":"Intermediate hyperhomocysteinaemia and compound heterozygosity for the common variant c.677C>T and a MTHFR gene mutation","volume":"30","author":"Rummel","year":"2007","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.pmr.2011.11.001_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000046735","article-title":"Plasma folate but not vitamin B(12) or homocysteine concentrations are reduced after short-term vitamin B(6) supplementation","volume":"45","author":"Bosy-Westphal","year":"2001","journal-title":"Ann Nutr Metab"},{"issue":"6","key":"10.1016\/j.pmr.2011.11.001_bib22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.mehy.2011.09.009","article-title":"Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress","volume":"77","author":"Hoffman","year":"2011","journal-title":"Med Hypotheses"},{"issue":"3","key":"10.1016\/j.pmr.2011.11.001_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000090737","article-title":"Influence of vitamin C and E supplementation on oxidative stress induced by hyperbaric oxygen in healthy men","volume":"50","author":"Bader","year":"2006","journal-title":"Ann Nutr Metab"},{"issue":"5","key":"10.1016\/j.pmr.2011.11.001_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2141.2005.05913.x","article-title":"Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap","volume":"132","author":"Smulders","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pmr.2011.11.001_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nn1609","article-title":"Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse","volume":"9","author":"Aoyama","year":"2005","journal-title":"Nat Neurosci"},{"issue":"11","key":"10.1016\/j.pmr.2011.11.001_bib26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.987","article-title":"Putting the DNA back into DNA methylation","volume":"43","author":"Bird","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.pmr.2011.11.001_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/341354","article-title":"Hyperhomocysteinemia due to methionine synthase deficiency, cblG structure of the MTR gene, genotype diversity, and recognition of a common mutation, p1173L","volume":"71","author":"Watkins","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.pmr.2011.11.001_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12020-009-9218-7","article-title":"Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy","volume":"36","author":"Ukinc","year":"2009","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.pmr.2011.11.001_bib29","first-page":"132","article-title":"Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5\u2032-phosphate","volume":"7","author":"Walker","year":"2010","journal-title":"Rev Neurol Dis"},{"issue":"1","key":"10.1016\/j.pmr.2011.11.001_bib30","first-page":"19","article-title":"L-methylfolate plus SSRI or SNRI from treatment initiation compared to SSRI or SNRI monotherapy in a major depressive episode","volume":"8","author":"Ginsberg","year":"2011","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.pmr.2011.11.001_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.69.2.228","article-title":"Homocysteine, folate, methylation, and monoamine metabolism in depression","volume":"69","author":"Bottiglieri","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.pmr.2011.11.001_bib32","doi-asserted-by":"crossref","first-page":"e22742","DOI":"10.1371\/journal.pone.0022742","article-title":"Incubating isolated mouse EDL muscles with creatine improves force production and twitch kinetics in fatigue due to reduction in ionic strength","volume":"6","author":"Head","year":"2011","journal-title":"PLoS One"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965111001008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965111001008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T03:35:05Z","timestamp":1760931305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965111001008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1047965111001008"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2011.11.001","relation":{},"ISSN":["1047-9651"],"issn-type":[{"value":"1047-9651","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypohomocysteinemia: A Potentially Treatable Cause of Peripheral Neuropathology?","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2011.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}